Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Condition:   Pancreatic Neoplasms Interventions:   Drug: nab-Paclitaxel+Gemcitabine;   Radiation: split-course SBRT Sponsor:   Fujian Medical University Union Hospital Recruiting

Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials